[go: up one dir, main page]

DK2964199T3 - Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler - Google Patents

Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler Download PDF

Info

Publication number
DK2964199T3
DK2964199T3 DK14710757.7T DK14710757T DK2964199T3 DK 2964199 T3 DK2964199 T3 DK 2964199T3 DK 14710757 T DK14710757 T DK 14710757T DK 2964199 T3 DK2964199 T3 DK 2964199T3
Authority
DK
Denmark
Prior art keywords
pharmaceutical compositions
active substance
carrier particles
dry pharmaceutical
nanoparticles bonded
Prior art date
Application number
DK14710757.7T
Other languages
English (en)
Inventor
Maynard Emanuel Lichty
Garry T Gwozdz
Original Assignee
Besins Healthcare Lu Sarl
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Besins Healthcare Lu Sarl filed Critical Besins Healthcare Lu Sarl
Application granted granted Critical
Publication of DK2964199T3 publication Critical patent/DK2964199T3/da

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A61K31/573Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone substituted in position 21, e.g. cortisone, dexamethasone, prednisone or aldosterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/38Cellulose; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605Excipients; Inactive ingredients
    • A61K9/1629Organic macromolecular compounds
    • A61K9/1652Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1682Processes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18Feminine contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Otolaryngology (AREA)
  • Urology & Nephrology (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14710757.7T 2013-03-04 2014-03-03 Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler DK2964199T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361772095P 2013-03-04 2013-03-04
PCT/US2014/019833 WO2014137877A1 (en) 2013-03-04 2014-03-03 Dry pharmaceutical compositions comprising active agent nanoparticles bound to carrier particles

Publications (1)

Publication Number Publication Date
DK2964199T3 true DK2964199T3 (da) 2020-06-15

Family

ID=47901822

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14710757.7T DK2964199T3 (da) 2013-03-04 2014-03-03 Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler

Country Status (23)

Country Link
US (2) US10695295B2 (da)
EP (1) EP2964199B1 (da)
JP (1) JP6564708B2 (da)
CN (1) CN105307639B (da)
AU (1) AU2014226192B2 (da)
BR (1) BR112015021525B1 (da)
CA (1) CA2901015A1 (da)
CY (1) CY1124635T1 (da)
DK (1) DK2964199T3 (da)
ES (1) ES2804702T3 (da)
HR (1) HRP20201103T1 (da)
HU (1) HUE050050T2 (da)
IL (1) IL240867B (da)
LT (1) LT2964199T (da)
MX (1) MX2015011624A (da)
PL (1) PL2964199T3 (da)
PT (1) PT2964199T (da)
RS (1) RS60481B1 (da)
RU (1) RU2715714C2 (da)
SI (1) SI2964199T1 (da)
SM (1) SMT202000349T1 (da)
WO (1) WO2014137877A1 (da)
ZA (1) ZA201505852B (da)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2804702T3 (es) 2013-03-04 2021-02-09 Besins Healthcare Lu Sarl Composiciones farmacéuticas secas que comprenden nanopartículas de agente activo unidas a partículas de portador
MX2019001313A (es) 2016-08-05 2019-09-26 Shin Nippon Biomedical Laboratories Ltd Composiciones farmaceuticas.
WO2018213452A1 (en) * 2017-05-19 2018-11-22 Jackson Milton S Appetite suppressant
JP7453770B2 (ja) 2019-10-25 2024-03-21 松本油脂製薬株式会社 複合粒子及びその製造方法
WO2022269556A1 (en) * 2021-06-25 2022-12-29 Nicoventures Trading Limited Oral products and method of manufacture

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS59163313A (ja) 1983-03-09 1984-09-14 Teijin Ltd 経鼻投与用ペプチドホルモン類組成物
FR2575678B1 (fr) 1985-01-04 1988-06-03 Saint Gobain Vitrage Ejecteur pneumatique de poudre
DK546289D0 (da) * 1989-11-02 1989-11-02 Danochemo As Carotenoidpulvere
IE67345B1 (en) * 1991-03-12 1996-03-20 Akzo Nv Low dose dry pharmaceutical preparations
GB9211268D0 (en) * 1992-05-28 1992-07-15 Ici Plc Salts of basic peptides with carboxyterminated polyesters
US5785049A (en) 1994-09-21 1998-07-28 Inhale Therapeutic Systems Method and apparatus for dispersion of dry powder medicaments
US5958458A (en) 1994-06-15 1999-09-28 Dumex-Alpharma A/S Pharmaceutical multiple unit particulate formulation in the form of coated cores
DE69724272T3 (de) * 1996-02-27 2007-05-10 Teijin Ltd. Puderförmige zusammensetzung zur nasalen anwendung
CA2341732C (en) 1998-08-26 2008-08-19 Teijin Limited Powder composition for nasal administration
US6117446A (en) * 1999-01-26 2000-09-12 Place; Virgil A. Drug dosage unit for buccal administration of steroidal active agents
IL144760A0 (en) 1999-12-08 2002-06-30 Pharmacia Corp Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
KR20030027108A (ko) 2001-07-05 2003-04-03 트렌스레셔널 리서치 가부시키가이샤 인슐린의 경비 투여용 조성물
CN1176649C (zh) 2002-10-16 2004-11-24 上海医药工业研究院 舒马普坦干粉吸入剂及其制备方法
MXPA05008140A (es) 2003-01-31 2005-09-30 Orexo Ab Una composicion farmaceutica de rapida accion.
US7638138B2 (en) 2003-02-21 2009-12-29 Translational Research, Ltd. Compositions for nasal administration of pharmaceuticals
EP1785145A4 (en) 2004-08-10 2008-08-13 Translational Res Ltd TRANSNASAL COMPOSITION WITH IMMEDIATE EFFECT AND HIGH RESORBIBILITY
US7947308B2 (en) * 2005-07-20 2011-05-24 Raimar Loebenberg Effervescent powders for inhalation
US20070178166A1 (en) 2005-12-15 2007-08-02 Acusphere, Inc. Processes for making particle-based pharmaceutical formulations for pulmonary or nasal administration
US20080057129A1 (en) * 2006-04-03 2008-03-06 Lerner E I Drug microparticles
GB0625322D0 (en) * 2006-12-19 2007-01-24 Pharmakodex Ltd Pharmaceutical compositions
CN101668544B (zh) * 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
GB0716907D0 (en) 2007-08-31 2007-10-10 Archimedes Dev Ltd Pharmaceutical powder compositions
US20110250274A1 (en) * 2008-09-19 2011-10-13 Shaked Ze Ev Estriol formulations
US9101539B2 (en) 2009-05-15 2015-08-11 Shin Nippon Biomedical Laboratories, Ltd. Intranasal pharmaceutical compositions with improved pharmacokinetics
TWI707700B (zh) * 2009-05-29 2020-10-21 美商沛爾醫療股份有限公司 用於經由肺部遞送長效蕈毒鹼拮抗劑及長效β2腎上腺素受體激動劑之組成物,及相關方法及系統
US20110262502A1 (en) 2010-02-08 2011-10-27 Prairie Pharmaceuticals LLC Pulmonary delivery of 17-hydroxyprogesterone caproate (17-hpc)
CA2796646A1 (en) * 2010-04-22 2011-10-27 Vertex Pharmaceuticals Incorporated Pharmaceutical compositions and administrations thereof
JP2014504260A (ja) * 2010-10-15 2014-02-20 グラクソ グループ リミテッド 集合ナノ粒子状薬物製剤、その製造及び使用
EP2540281A1 (en) * 2011-06-30 2013-01-02 LEK Pharmaceuticals d.d. Solid self-microemulsifying systems
ES2804702T3 (es) 2013-03-04 2021-02-09 Besins Healthcare Lu Sarl Composiciones farmacéuticas secas que comprenden nanopartículas de agente activo unidas a partículas de portador

Also Published As

Publication number Publication date
SI2964199T1 (sl) 2020-10-30
SMT202000349T1 (it) 2020-09-10
RU2015141792A (ru) 2017-04-07
ZA201505852B (en) 2017-07-26
EP2964199A1 (en) 2016-01-13
JP2016510742A (ja) 2016-04-11
IL240867B (en) 2020-11-30
LT2964199T (lt) 2020-08-10
CN105307639B (zh) 2020-06-30
PT2964199T (pt) 2020-05-12
AU2014226192B2 (en) 2018-07-26
IL240867A0 (en) 2015-10-29
ES2804702T3 (es) 2021-02-09
MX2015011624A (es) 2015-12-17
HUE050050T2 (hu) 2020-11-30
EP2964199B1 (en) 2020-04-22
CN105307639A (zh) 2016-02-03
CY1124635T1 (el) 2022-03-24
JP6564708B2 (ja) 2019-08-21
US10918601B2 (en) 2021-02-16
US20200390706A1 (en) 2020-12-17
PL2964199T3 (pl) 2021-01-25
US10695295B2 (en) 2020-06-30
BR112015021525B1 (pt) 2022-06-14
AU2014226192A1 (en) 2015-09-03
HRP20201103T1 (hr) 2021-02-05
BR112015021525A2 (pt) 2017-07-18
CA2901015A1 (en) 2014-09-12
RS60481B1 (sr) 2020-08-31
US20140248367A1 (en) 2014-09-04
RU2715714C2 (ru) 2020-03-03
AU2014226192A8 (en) 2016-04-21
RU2015141792A3 (da) 2018-03-01
WO2014137877A1 (en) 2014-09-12

Similar Documents

Publication Publication Date Title
FR21C1059I2 (fr) Compositions pharmaceutiques
IL244113A0 (en) Selective delivery of material to cells
DK3054920T3 (da) Tørpulverinhalator
DK3398638T3 (da) Tørpulverinhalator
EP2841056A4 (en) STABLE LAYER COATED PARTICLES
FR3006556B1 (fr) Atomiseur etanche
DK3030262T3 (da) Kombineret farmaceutisk sammensætning
DK3033102T3 (da) Peptidkonjugerede partikler
CL2014003370A1 (es) Composición acuosa estable de anticuerpos anti-baffr; y dispositivo de suministro de la composición.
DK3181128T3 (da) Farmaceutisk nilotinib-sammensætning
CL2014002051A1 (es) Composiciones plaguicidas y procesos relacionados con dichas composiones
DK2863942T3 (da) Peptidkonjugerede partikler
SMT201500320B (it) Liofilizzazione di agente tensioattivo polmonare liposomale sintetico
DK3043778T3 (da) Farmaceutiske sammensætninger, der indeholder refametinib
HUE051111T2 (hu) Foszfát kötõanyag részecskéket tartalmazó gyógyszerkészítmény
DK2964199T3 (da) Tørre farmaceutiske sammensætninger omfattende aktivstof-nanopartikler bundet til bærerpartikler
DK2919761T3 (da) Fast doseringsform omfattende mikroniseret cytisin
BR112015002646A2 (pt) composto e composição farmacêutica
EP3010982A4 (en) SEPARATION OF SOLID PARTICLES
EP2988734C0 (en) FORMULATION OF A HARD CAPSULE
CL2015002768A1 (es) Encapsulación de ingredientes activos y métodos para prepararlos
DK2994136T3 (da) Nikotinpastilformulering
EP3043648C0 (en) PHARMACEUTICAL BENDAMUSTIN COMPOSITIONS
EP2976130A4 (en) STRUCTURING OF A COSMETIC COMPOSITION USING ORGANOGELES
DK2908836T3 (da) Farmaceutisk formulering indeholdende curcuma